The Potent New Anti-Tumor Immunotherapies Organizer(s): Nicholas P. Restifo Date: March 28 - April 02, 2007
Location: Fairmont Banff Springs, Banff, AB, CanadaFor the first time, significant numbers of patients with some solid cancer histologies can be successfully treated using immunological means. Progress in our understanding of immune activation, homeostasis and regulation has reached a “tipping point” that has enabled the development of multiple anti-tumor immune-based strategies. Adoptive cell transfer (ACT) of anti-tumor T cells after the depletion host immune cells causes objective regression in about 50% of the patients. Work on therapeutic cancer vaccines is intensive and will actively be discussed at the meeting. The challenge now is to control and direct the potent new weapons in at the immunotherapist’s disposal. This meeting will bring the key scientists who are securing the basic foundations of the new immunology and the translational immunotherapists who are pioneering strategies that objectively work in the clinic. Scholarship Deadline: November 28 2006 Discounted Abstract Deadline: November 28 2006 Abstract Deadline: January 12 2007 Discounted Registration Deadline: January 29 2007 We gratefully acknowledge additional support for this conference from:  |